Latest

neuropharmacology

This shows a cannabis plant, seeds, and a dropped bottle

Brain Cancer Featured Neuroscience Open Neuroscience Articles Pain

·May 20, 2022·4 min read

Medicinal Cannabis Shown to Reduce Pain and Need for Opiate Painkillers Among Cancer Patients

Most cancer patients who used medical cannabis reported a significant improvement in pain measures and a decrease in some other cancer-related symptoms. Additionally, medical cannabis use reduced the consumption of traditional, opioid-based pain killers for those with cancer.

Featured Neurology Neuroscience

·April 30, 2022·4 min read

A New Treatment Reduces Inflammation in Multiple Sclerosis Mice Models

Administering a lipid that mediates inflammation reduced chronic inflammation associated with multiple sclerosis in mouse models. Researchers found these mediator lipids are reduced in humans with multiple sclerosis.

Featured Neuroscience Open Neuroscience Articles

·April 23, 2022·4 min read

Fetal Exposure to Antidepressants May Affect Infants’ Brain Development

Fetal exposure to antidepressants or antiepileptic medications may affect the development of newborn brain networks.

This shows a sleeping woman surrounded by clouds

Featured Neuroscience

·April 18, 2022·2 min read

Drug Reduced Frequency of Breathing Pauses in Sleep Apnea

Sulthiame, a CA inhibitor drug, reduced the number of breathing pauses and promoted oxygenation during the night in sufferers of obstructive sleep apnea.

This cartoon shows a brain with a lock around it and a man holding a key

Featured Neuroscience Open Neuroscience Articles Psychology

·April 14, 2022·5 min read

A Drug That Cures Alcoholism May Be the Next Anti-anxiety Medication

Disulfiram, a drug commonly prescribed to treat chronic alcohol addiction, was shown to reduce anxiety levels in rodent models. The drug inhibits FROUNT protein and chemokine signaling pathways under its influence, suppressing overall glutamate transmission in the brain. This, in turn, helps reduce overall activity. The findings may signal a new way to treat anxiety in humans.

This shows a woman in a facemask holding a flower

Featured Neurology Neuroscience

·April 10, 2022·6 min read

A Way to Prevent Loss of Smell and Taste From COVID-19

Camostat mesylate, an oral medication commonly prescribed to treat pancreatitis, reduces both the loss of smell and taste in those with COVID-19 infection.

This shows a psychedelic image of a woman's head

Featured Neuroscience Open Neuroscience Articles Psychology

·April 7, 2022·3 min read

Psilocybin Use Associated With Lower Risk of Opioid Addiction

Opioid use disorder is 30% less common in those who used psilocybin compared to those who have never been exposed to the psychedelic. Researchers say psilocybin may protect against opioid addiction by affecting the transmission of dopamine and serotonin.

This shows the outline of two heads made up of tree branches

Featured Neurology Neuroscience

·March 29, 2022·4 min read

Promising Alzheimer’s Drug May Also Improve Memory in Down Syndrome and Normal Aging

GM-CSF/sargramostim, a drug that improved memory in Alzheimer's patients during a phase II clinical trial, also appears to improve cognitive function in older adults and those with Down syndrome.

Featured Neuroscience

·March 23, 2022·6 min read

Oral Drug Prevents Death From COVID-19 in Old Mice by Reversing Immune Aging

BGE-175, an oral drug that reverses multiple aspects of immune aging effectively prevents death in mouse models of COVID-19.

Featured Neurology Neuroscience

·March 23, 2022·3 min read

Do Older Adults Using Statins Have Lower Risk of Developing Parkinsonism Later?

Older adults who take statin drugs have a lower risk of developing Parkinson's disease or parkinsonism symptoms later in life compared to those who do not take statins. Researchers speculate this may be because statins have a neuroprotective effect on arteries in the brain.